Sort
40,608 grants matching “prostate cancer”
MSKCC CENTER FOR IN VIVO MOLECULAR IMAGING IN CANCER
$2,000,000Sloan-Kettering Institute For Cancer Res · P50 · FY2003 · CA
CENTER FOR SINGLE PHOTON-EMITTING CANCER IMAGING AGENTS
$1,999,999University Of Missouri-Columbia · P50 · FY2003 · CA
Development of an Innovative PSMA-Targeted Small Molecule Prodrug for Prostate Cancer
$1,999,998Beatrice Langton-Webster · Cancer Targeted Technology, Llc · R44 · FY2025 · CA
6 MeV/amu ion linac for deep-penetration microbeam and millimeter-beam charged-particle irradiations in small animals and biological tissues
$1,999,985David Jonathan Brenner · Columbia University Health Sciences · S10 · FY2018 · OD
RadTox - Measuring Radiation Toxicity using Circulating DNA
$1,999,984Aiguo Zhang · Diacarta, Llc · N01 · FY2018 · CA
MSKCC Center for Molecular Imaging in Cancer
$1,999,955Ronald G Blasberg · Sloan-Kettering Inst Can Research · P50 · FY2006 · CA
Building CER Capacity: Aligning CRN, CMS, and State Resources to Map Cancer Care
$1,999,936Jane C. Weeks · Dana-Farber Cancer Inst · RC2 · FY2009 · CA
IGF::OT::IGF (CHAMPIONS ONCOLOGY)To address the slow growth rate of prostate PDXs by eliminating logistical barriers through development of CDX (i.e., PDX from circulating tumor cells) models. PERIOD
$1,999,931Peter Kipp · Champions Oncology, Inc. · N44 · FY2017 · CA
TOPIC 368: TREATMENT OPTIMIZATION BY COMBINED A-EMITTER (ARPT)/RADIOTHERAPY (XRT) DOSIMETRY FOR PROSTATE CANCER PATIENTS
$1,999,796Michael Ghaly · Radiopharmaceutical Imaging And Dosimetry, Llc · N44 · FY2019 · CA
Big Omics Data Engine 2 Supercomputer
$1,998,264Patricia Kovatch · Icahn School Of Medicine At Mount Sinai · S10 · FY2019 · OD
SBIR TOPIC 401 PHASE II:
$1,998,128Ph.d., Peymon Ghazi · Malcova Inc · N44 · FY2023 · CA
Highly Parallel Supercomputing for Translational Research
$1,996,810Edward B Suh · Translational Genomics Research Inst · S10 · FY2008 · RR
IGF::OT::IGF SBIR Phase II: Topic 338 - Predictive Biomarkers of Adverse Reactions to Prostrate Cancer Radiotherapy
$1,996,011Elizabeth Peterson-Roth · L2 Diagnostics, Llc · N44 · FY2017 · CA
Detroit Research on Cancer Survivors (Detroit ROCS)
$1,995,543Ann G Schwartz · Wayne State University · U01 · FY2018 · CA
Molecular Mechanism of Action of Phorbol Ester
$1,995,350Peter Blumberg · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Prostate Cancer Susceptibility: The ICPCG Study
$1,994,849Johns Hopkins University · U01 · FY2005 · CA
IGF::OT::IGFNCI SBIR Phase II Topic 346: Molecularly Targeted Radiation Therapy for Cancer TreatmentTitle: Targeted Radionuclide Therapy of Neuroendocrine Tumors using 212Pb-octreotate Analogs
$1,994,002Izabela Tworowska · Radiomedix, Inc. · N01 · FY2018 · CA
SPORE in Prostate Cancer
$1,993,426Samuel R Denmeade · Johns Hopkins University · P50 · FY2017 · CA
Investigating cell-intrinsic and extrinsic interactions in prostate cancer at the single cell level
$1,992,818Michael M. Shen · Columbia University Health Sciences · P01 · FY2024 · CA
SYNTHETIC IMMUNE RECEPTOR FOR THE TREATMENT OF PROSTATE CANCER
$1,992,000University Of Southern California · · FY2025 · Defense Health Agency
CENTER OF EXCELLENCE FOR PROSTATE CANCER RESEARCH, EDUCATION AND COMMUNITY SERVIC
$1,991,327Shafiq A Khan · Clark Atlanta University · P20 · FY2011 · MD
LASER CELL PROCESSING FOR BASIC AND CLINICAL RESEARCH
$1,990,955Cyntellect, Inc. · R44 · FY2002 · RR
Microbes and Human Malignancies
$1,990,497James J Goedert · Division Of Cancer Epidemiology And Genetics · ZIA · FY2010 · CA
Androgen Receptor Action in Castration Resistant Prostate Cancer
$1,990,456Steven P. Balk · Beth Israel Deaconess Medical Center · P01 · FY2025 · CA
PREDICTING PROSTATE CANCER PROGRESSION AT TIME OF DIAGNOSIS
$1,990,066Regents Of The University Of California, San Francisco, The · · FY2011 · Department of Defense